Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Cognitive-Behavioral Therapy for Opiate Users in Methadone Treatment: A Multicenter Randomized Controlled Trial

Mahmood Amini-Lari 1 , * , Zahra Alammehrjerdi 2 , Fatemeh Ameli 1 , Hassan Joulaei 3 , Reza Daneshmand 4 , Hossain Faramarzi 5 , Hamid-Reza Bakhtiyari 1 and Roya Samadi 6
Authors Information
1 Shiraz HIV/AIDS Research Center, Health Institute, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, IR Iran
3 Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
5 Larestan University of Medical Sciences, Larestan, Fars, IR Iran
6 Psychiatry and Behavioral Sciences Research Center, Department of Psychiatry, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e9302
  • Published Online: March 4, 2017
  • Article Type: Original Article
  • Received: October 9, 2016
  • Revised: January 22, 2017
  • Accepted: February 24, 2017
  • DOI: 10.5812/ijpbs.9302

To Cite: Amini-Lari M, Alammehrjerdi Z, Ameli F, Joulaei H, Daneshmand R, et al. Cognitive-Behavioral Therapy for Opiate Users in Methadone Treatment: A Multicenter Randomized Controlled Trial, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e9302. doi: 10.5812/ijpbs.9302.

Copyright © 2017, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Saberi Zafarghandi MB, Jadidi M, Khalili N. Iran's Activities on Prevention, Treatment and Harm Reduction of Drug Abuse. Int J High Risk Behav Addict. 2015; 4(4)[DOI][PubMed]
  • 2. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J. 2012; 9: 18[DOI][PubMed]
  • 3. Kheradmand A, Amini Ranjbar Z, Zeynali Z, Sabahy AR, Nakhaee N. Sleep Quality and Sexual Function in Patients Under Methadone Maintenance Treatment. Int J High Risk Behav Addict. 2015; 4(4)[DOI][PubMed]
  • 4. Sheikh Fathollahi M, Torkashvand F, Najmeddin H, Rezaeian M. Predictors of One-Year Retention in Methadone Maintenance Treatment (MMT) in Iran, Rafsanjan. Int J High Risk Behav Addict. 2016; 5(3)[DOI][PubMed]
  • 5. Pashaei T, Moeeni M, Roshanaei Moghdam B, Heydari H, Turner NE, Razaghi EM. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis. J Res Health Sci. 2014; 14(4): 291-5[PubMed]
  • 6. Babaie E, Razeghi N. Comparing the effects of methadone maintenance treatment, therapeutic community, and residential rehabilitation on quality of life and mental health of drug addicts. Addict Health. 2013; 5(1-2): 16-20[PubMed]
  • 7. Seyedfatemi N, Peyrovi H, Jalali A. Relapse experience in Iranian opiate users: a qualitative study. Int J Community Based Nurs Midwifery. 2014; 2(2): 85-93[PubMed]
  • 8. Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016; 111(10): 1836-47[DOI][PubMed]
  • 9. Feeney GF, Connor JP, Young RM, Tucker J, McPherson A. Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT). Addict Behav. 2006; 31(10): 1833-43[DOI][PubMed]
  • 10. Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA. A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend. 2016; 160: 135-42[DOI][PubMed]
  • 11. Reback CJ, Shoptaw S. Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men. Addict Behav. 2014; 39(8): 1286-91[DOI][PubMed]
  • 12. Jaffe A, Shoptaw S, Stein J, Reback CJ, Rotheram-Fuller E. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Exp Clin Psychopharmacol. 2007; 15(3): 301-7[DOI][PubMed]
  • 13. American Psychiatric Association. . Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR R-. 2000;
  • 14. Azizi A, Borjali A, Golzari M. The effectiveness of emotion regulation training and cognitive therapy on the emotional and addictional problems of substance abusers. Iran J Psychiatry. 2010; 5(2): 60-5[PubMed]
  • 15. Biener L, Abrams DB. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991; 10(5): 360-5[DOI][PubMed]
  • 16. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90(5): 607-14[DOI][PubMed]
  • 17. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction. 2005; 100(3): 367-78[DOI][PubMed]
  • 18. Suvanchot KS, Somrongthong R, Phukhao D. Efficacy of group motivational interviewing plus brief cognitive behavior therapy for relapse in amphetamine users with co-occurring psychological problems at Southern Psychiatric Hospital in Thailand. J Med Assoc Thai. 2012; 95(8): 1075-80[PubMed]
  • 19. Tait RJ, McKetin R, Kay-Lambkin F, Carron-Arthur B, Bennett A, Bennett K, et al. A Web-Based Intervention for Users of Amphetamine-Type Stimulants: 3-Month Outcomes of a Randomized Controlled Trial. JMIR Ment Health. 2014; 1(1)[DOI][PubMed]
  • 20. Nuijten M, Blanken P, van den Brink W, Hendriks V. Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. Drug Alcohol Depend. 2014; 138: 177-84[DOI][PubMed]
  • 21. Jiang H, Du J, Wu F, Wang Z, Fan S, Li Z, et al. Efficacy of contingency management in improving retention and compliance to methadone maintenance treatment: a random controlled study. Shanghai Arch Psychiatry. 2012; 24(1): 11-9[DOI][PubMed]
  • 22. Mokri A, Chawarski MC, Taherinakhost H, Schottenfeld RS. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. Addiction. 2016; 111(5): 874-82[DOI][PubMed]
  • 23. Hoseiny H, Jadidi M, Habiballah Nataj L, Saberi-Zafarghandi MB. The effect of methadone-maintenance therapy with and without interactive treatment on improving emotion-regulation strategies and resilience among opiate-dependent clients. Int J High Risk Behav Addict. 2015; 4(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments